title: Successful transcatheter aortic valve implantation for pure aortic regurgitation using a new second generation self-expanding J-Valve(TM) system - the first in-man implantation.
abstract: Transcatheter aortic valve implantation (TAVI) has been recognised as an effective treatment option for high-risk or inoperable patients with aortic stenosis. However, experience with TAVI for non-calcified aortic regurgitation is still limited. The new J-Valve(TM) prosthesis is designed for antegrade transapical implantation which is characterised by three U-shape graspers that could facilitate intuitive 'self-positioning' valve implantation and provide axial as well as radial fixation by embracing the native valve leaflets. Here we report the first in-man TAVI procedure of J-Valve(TM) prosthesis in a high risk patient with pure aortic regurgitation.
authors.affiliation: Department of Cardiovascular Surgery, West China Hospital, Sichuan University.
authors.forename: Da
authors.initials: D
authors.lastname: Zhu
authors.affiliation: Department of Cardiovascular Surgery, West China Hospital, Sichuan University.
authors.forename: Jia
authors.initials: J
authors.lastname: Hu
authors.affiliation: Department of Cardiovascular Surgery, West China Hospital, Sichuan University.
authors.forename: Wei
authors.initials: W
authors.lastname: Meng
authors.affiliation: Department of Cardiovascular Surgery, West China Hospital, Sichuan University. Electronic address: drguoyq@qq.com.
authors.forename: Yingqiang
authors.initials: Y
authors.lastname: Guo
mesh_terms: D000368:Aged; D001022:Aortic Valve Insufficiency / Q000601:surgery*; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male
keywords: High risk patient; J-Valve(TM) system; Pure aortic regurgitation; Second generation TAVI device; Trans-catheter aortic valve implantation (TAVI)